| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.78B | 1.75B | 1.71B | 1.24B | 712.30M |
| Gross Profit | 979.00M | 1.15B | 1.14B | 798.30M | 459.10M |
| EBITDA | 126.50M | 234.40M | 289.70M | 82.50M | 89.20M |
| Net Income | -547.50M | -192.00M | -56.40M | -120.60M | 49.90M |
Balance Sheet | |||||
| Total Assets | 2.10B | 2.67B | 2.75B | 2.95B | 400.11M |
| Cash, Cash Equivalents and Short-Term Investments | 264.30M | 265.40M | 256.20M | 317.60M | 175.31M |
| Total Debt | 1.89B | 1.83B | 1.75B | 1.79B | 22.90M |
| Total Liabilities | 2.77B | 2.77B | 2.67B | 2.79B | 275.70M |
| Stockholders Equity | -680.60M | -116.40M | 79.90M | 159.20M | 124.33M |
Cash Flow | |||||
| Free Cash Flow | 86.60M | 131.10M | 81.10M | -107.00M | 76.02M |
| Operating Cash Flow | 91.00M | 226.50M | 151.40M | -30.20M | 98.69M |
| Investing Cash Flow | -115.30M | -93.70M | -21.10M | -428.90M | -22.60M |
| Financing Cash Flow | -21.30M | -103.50M | -188.60M | 588.30M | -52.09M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | £92.76M | 16.31 | 15.38% | ― | 10.22% | -33.00% | |
65 Neutral | £1.02B | 0.79 | 99.57% | 163.36% | ― | ― | |
64 Neutral | £461.87M | 13.36 | 9.03% | 2.58% | 5.13% | 6.55% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | £3.42B | -5.40 | -57.07% | 2.24% | 3.34% | -47.20% | |
53 Neutral | £10.58M | 31.03 | ― | ― | ― | ― | |
51 Neutral | £170.03M | -0.31 | 125.82% | ― | 1.56% | -185.45% |